Digest Network Come funziona
Network
/
Società
Al
Non verificato

Alamar Biosciences, Inc.

Di cosa scriviamo

BiologiaBiotecnologiaEconomiaFarmaceuticaSanità

17 comunicati stampa

Guarda tutti i comunicati
28/07/2026
Biotecnologia
Medicina Salute Benessere
Annunci Economici
Alamar Biosciences Launches NULISAseq™ Immune 340 Panel for Comprehensive Profiling of the Immune Proteome
Fonte
Alamar Biosciences, Inc.
Emittente
GLOBENEWSWIRE
1.00
0
12/07/2026
Biotecnologia
Medicina Salute Benessere
Management/Organizzazione Aziendale
Alamar Biosciences Partners with Leading Research Universities to Launch National Initiative Advancing Blood-Based Biomarkers for Neurodegenerative Diseases
Fonte
Alamar Biosciences, Inc.
Emittente
GLOBENEWSWIRE
1.00
0
10/07/2026
Biotecnologia
Alamar Biosciences NULISA Data Featured in More Than 140 Scientific Presentations at AAIC 2026, Highlighting Advances in Blood-Based Alzheimer’s Biomarker Profiling
Fonte
Alamar Biosciences, Inc.
Emittente
GLOBENEWSWIRE
1.00
0
07/07/2026
Biotecnologia
Medicina Salute Benessere
Annunci Economici
Alamar Biosciences Launches the First Multiplexed Blood-based Immunoassay for eMTBR-Tau, One of the Most Important Biomarkers in Alzheimer’s Disease Research
Fonte
Alamar Biosciences, Inc.
Emittente
GLOBENEWSWIRE
1.00
0
02/06/2026
Biotecnologia
Medicina Salute Benessere
Annunci Economici
Alamar Biosciences Makes Home-Collected Fingerstick Samples Compatible with Ultra High-Sensitivity, Multiplex Proteomics
Fonte
Alamar Biosciences, Inc.
Emittente
GLOBENEWSWIRE
1.00
0
17/03/2026
Biotecnologia
Medicina Salute Benessere
Annunci Economici
Alamar Biosciences Launches NULISAseq™ Neuro 220 Panel, its largest precision proteomics panel with the sensitivity and specificity to advance neurological disease research
Fonte
Alamar Biosciences, Inc.
Emittente
GLOBENEWSWIRE
1.00
0
Press Release cover image
29/07/2025
Salute
Fitness
Cronaca Rosa / Gossip
Cronaca Bianca
Imprese
Industria
Medicina - Varie
Ecologia/Salute ambientale
Agricoltura
Alamar Biosciences and the German Center for Neurodegenerative Diseases (DZNE) partner for Landmark Proteomic Profiling study in the Rhineland Study Cohort
Fonte
Alamar Biosciences, Inc.
Emittente
PR News Wire
1.00
0
Press Release cover image
28/07/2025
Salute
Fitness
Fiere
Eventi
Medicina - Varie
Ecologia/Salute ambientale
Agricoltura
Alamar Biosciences Showcases Pioneering Brain-Derived pTau Data at the Alzheimer's Association International Conference (AAIC)
Fonte
Alamar Biosciences, Inc.
Emittente
PR News Wire
1.00
0
28/05/2025
Farmaceutica
Sanità
Economia
Brevetti, marchi e copyright
Biologia
Alamar Biosciences joins forces with SciLifeLab to advance understanding of human disease
Fonte
Alamar Biosciences, Inc.
Emittente
PR News Wire
1.00
0
15/05/2025
Farmaceutica
Information Technology
Telecomunicazioni
Sanità
Biologia
Alamar Biosciences Expands NULISAseq(TM) CNS Disease Panel 120 with Groundbreaking Blood-Based Brain-Derived pTau Assays
Fonte
Alamar Biosciences, Inc.
Emittente
PR News Wire
1.00
0

Recapiti

Social Media

Seguaci
0
Compatibilità
0